Neurotech2020 – bringing Longevity to a head

Neurotech2020 heads into its second week – and we are psyched for Longevity!

Neurotech2020 – the digital congress for neurotechnology innovation and growth – had a brilliant first week, and tomorrow sees the start of two days curated by your Longevity.Technology team.

Packed with presentations and discussions on neurological biomarkers, neuroprotection and machine learning, Neurotech2020 is the place to find out more about optimising lifespan and heathspan through the most exciting advances in neural technology.

The conference, which is founded by Alon Braun, Co-founder of, is completely virtual, for obvious reasons, with sessions for the next 5 days kicking off at 8am PST / 11am EST / 4pm UK / 5pm EU.

08 December – Longevity Day One

Moderated by our own Founder and CEO, Phil Newman, Day One starts with Jean Hébert, Professor of Neuroscience and Genetics at the Albert Einstein College of Medicine in New York. Professor Hébert trained as a molecular geneticist, and he is now developing ways to use replacement cells to repair and rejuvenate the brain. His new book argues that regenerative medicine is the key to Longevity, and in his presentation at Neurotech2020, he’ll be taking a look at cell transplantation for neocortical repair and revealing some of the clues needed for that journey.

Professor Jean Hérbert's new book Replacing Aging argues that regenerative medicine is the key to Longevity.
Jean Hebert – Cell Transplantation for Neocortical Repair – Clues on How to Get There

Next up is David Wood, futurist, author and singularitarian. A pioneer of the smartphone industry, Wood is the author of Smartphones and beyond: Lessons from the remarkable rise and fall of Symbian, and he will be using his knowledge and experience to talk us through accelerating technological disruption to make the journey from enhanced phones to enhanced brains.

David Wood – From enhanced phones to enhanced brains.

We featured an interview with Dr Randall Williams, Managing Director of, last week, in which we spoke to him about leveraging technology such as smart speakers and virtual assistants to support continued independence in our rapidly aging society. He will explore the role of this tech further in his presentation as he overviews the detection and tracking of cognitive decline, asking “Can Alexa Best The Academic Experts?”

Randall Williams,
Randall Williams – Detecting and Tracking Cognitive Decline: Can Alexa Best The Academic Experts?

Amir Bozorgzadeh, the Co-founder & CEO of VirtuLeap will reveal just how VR is unlocking the neurosciences, and Zoltan Istvan, author of Transhumanist Bill of Rights and former US Presidential Candidate will present on just what transhumanism means for the Longevity movement.

Amir Bozorgzadeh
Amir Bozorgzadeh – How VR is unlocking the neurosciences.

Dr José Cordeiro, futurist, author and Executive Director of the Ibero-American Futurists Network (RIBER) will posit that the death of death itself can be achieved through neuro and biological immortality, and Dr Owen Phillips, CEO & Co-Founder of Brainkey, will explain the concept of Brain Age, revealing exactly what it is, and why it is important.

Jose Cordeiro – The death of death: neuro and biological immortality.

Rounding off Day One, Dr Bernardo Kastrup, a scientist and metaphysical idealist will explore what reality and life means from a neuro-perspective, and Dr Dan Rizzuto, the CEO of Nia Therapeutics will present on personalised neurostimulation therapy and how it can restore memory after brain injury and disease.

Dan Rizzuto – Personalized neurostimulation therapy to restore memory after brain injury and disease.

09 December – Longevity Day Two

Joining Phil Newman to support Day Two’s programme is Dr Richard Siow, Director of Ageing Research at King’s (ARK), a multidisciplinary consortium of researchers working on aging at King’s College London.

Richard Siow – co-host. Director of Ageing Research King’s College London (ARK)

Anthony DePasqua, the CEO & Co-Founder of EnClear Therapies, is first up on Day Two; he will be speaking about improving Longevity by using the technique of accessing CSF to clear age-related toxicity from the brain and spine.

Longevity start-up EnClear Therapies targets neurodegenerative disease with therapeutic filtration technology - Anthony DePasqua
Anthony DePasqua – Longevity, accessing CSF to clear age related toxicity from the brain and spine.

Following is the CEO and co-founder of BIOS, Emil Hewage, detailing BIOS Health’s work in leveraging recent breakthroughs in AI and Machine Learning to isolate neural biomarkers to precisely link nerve activity to specific chronic health conditions.

Emil Hewage – We would like to present BIOS Health’s work in leveraging recent breakthroughs in AI and Machine Learning to isolate neural biomarkers to precisely link nerve activity to specific chronic health conditions.

Professor Uri Ashrey, of the Sagol School of Neuroscience will spotlight the use of Hyperbaric Oxygen Therapy (HBOT) in Alzheimer’s disease, covering the ground-breaking research that made the headlines recently and Joe Geraci, the Chief AI Officer & President of Netramark will have a live demonstration of Netramark’s unique interactive AI platform for R&D acceleration. This suite of technologies is allowing Netramark to impact neurodegeneration by providing new perspectives on disorders.

Uri Ashery – Neurodegenerative disease and the use of Hyperbaric Oxygen Therapy (HBOT) in Alzheimer’s disease.

Rohit Talwar, the CEO of Fast Future will look at the Longevity marketplace, presenting on how to cross it over into the mainstream, and Bruce Duncan, the Managing Director of the Terasem Movement Foundation has an interactive programme for the audience which will feature including a Q&A with the Foundation’s android Bina48.

Following on, the Chief Scientist and CEO of Neural Signals Inc, Dr Phil Kennedy, will tackle the subject of locked-in syndrome. Can the Longevity of locked-in people be extended by using the speech prosthetic for silent speech? Dr Marios Kyriazis, a biomedical gerentologist who works with the ELPIs Foundation for Indefinite Lifespans to study the elimination of age-related degeneration will argue that cognitive hormesis can reduce age-related degeneration.

Richard Hanbury – Audiovisual neuromodulation for pain, mental health relief, and improving wellbeing. A novel device undergoing multiple pivotal FDA trials.

Richard Hanbury, the CEO of Sana Health will round off Day Two; his personal experience with car accident-induced nerve pain led him to develop a wearable that will help all patients who suffer from chronic pain, and Sana Health now has a novel device undergoing multiple pivotal FDA trials. Hanbury will present on this and how audiovisual neuromodulation can tackle pain, bring mental health relief and improve wellbeing.

Neurotech2020 – find out more and grab your free ticket, or all-access VIP pass HERE.